Situational awareness: Walgreens Boots Alliance is paying about $1.37 billion for the remaining 30% stake not owned in Shields Health Solutions, a hospital-facing specialty pharmacy company — providing a full exit for Welsh, Carson, Anderson & Stowe.
A year ago, Walgreens boosted its Shield stake to 70% at a roughly $2.5 billion valuation, sources told Axios previously.